XBiotech Inc.
XBITNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for XBIT. That does not mean none is planned.
Get an email about XBIT's next catalysts
Track XBiotech (XBIT) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
XBIT Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | FQ end Sep/2026 | Call: tbd
Market Overview
Stock performance and key metrics
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.
WebsiteNatrunix
Rheumatoid Arthritis
3 plus standard antibiotic treatment
Staphylococcus Aureus Bacteremia
Phase I: XB2001
Pancreatic Cancer
Phase II: XB2001
Pancreatic Cancer
3 plus standard antibiotic treatment: Phase II
Staphylococcus Aureus Bacteremia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Natrunix | Phase 2 | Rheumatoid Arthritis | - | - |
3 plus standard antibiotic treatment | Phase 2 | Staphylococcus Aureus Bacteremia | - | - |
Phase I: XB2001 | Phase 2 | Pancreatic Cancer | - | - |
Phase II: XB2001 | Phase 2 | Pancreatic Cancer | - | - |
3 plus standard antibiotic treatment: Phase II | Phase 2 | Staphylococcus Aureus Bacteremia | - | - |
Staphylococcus Aureus Bacteremia
2 drugs in this indication
Rheumatoid Arthritis
1 drug in this indication
Pancreatic Cancer
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Frequently asked questions
What is in XBiotech Inc.'s drug pipeline?→
CatalystAlert tracks 5 drug candidates in XBiotech Inc.'s (XBIT) pipeline across Phase 2. Its lead program is 3 plus standard antibiotic treatment (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is XBiotech Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for XBiotech Inc. (XBIT) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track XBIT biotech catalysts?→
Add XBIT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow XBiotech Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.